Clinical News

Skin Cancer Risk Factors Identified in Asian Americans

2 hours ago

By Armand Butera

Despite being the fastest growing racial group in the United States, Asian Americans have remained underrepresented in health disparities research.

Making Sense of Trial Eligibility for Schizophrenia Studies

3 hours ago

By Kenny Walter

Ineligible patients with schizophrenia have a higher risk of hospitalization for a number of reasons, including suicide attempts.

Role of VEGF Inhibitors in Retinal Diseases

3 hours ago

By John W. Kitchens, MD

Dante J. Pieramici, MD, leads the discussion on the use of VEGF inhibitors for retinal diseases other than wet AMD.

Treatment Selection of Anti-VEGF Agents for Wet AMD

3 hours ago

By John W. Kitchens, MD

Dante J. Pieramici, MD, leads the discussion on factors to consider when selecting the optimal therapy for patients with wet AMD.

Insomnia Associated with Traumatic Brain Injury in Adult Patients

4 hours ago

By Armand Butera

Significant associations between insomnia and race, sex, and psychiatric history were also observed.

Crisis Point - Obesity Crisis

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

Conference Coverage

View All >>

Better Minority Enrollment Needed in UK Multiple Myeloma Trials

December 14, 2021

By Kenny Walter

The enrollment distribution was consistent by ethnicity over the course of 18 years, with no change in diversity over time despite there being an increase in the UK in the minority population.

Fuad El Rassi, MD, Tracks COVID-19 and Sickle Cell Disease For a Year

December 14, 2021

By Giuliana Grossi

Of the SCD patients who contracted COVID-19, 49% of them visited the Grady Comprehensive Sickle Cell center because of a vaso-occlusive event.

Identifying Distinct Cognitive Profiles Of Adults With SCD May Reduce Morbidity

December 14, 2021

By Connor Iapoce

Data show patients with sickle cell disease identified by distinct cognitive profile should have neurorehabilitation tailored to each unique profile.

Voxelotor May Improve Exercise Capacity In Patients With Sickle Cell Anemia

December 14, 2021

By Connor Iapoce

After 2 months of voxelotor treatment, all patients with sickle cell anemia perceived global improvement, but peak VO2 did not change in 8 of 9 patients.

Video Series

View All >>

Role of VEGF Inhibitors in Retinal Diseases

Treatment Selection of Anti-VEGF Agents for Wet AMD

Hybrid Artificial Insulin Pump Systems for T2DM

Integrating Continuous Glucose Monitoring Systems into Clinical Practice

Managing Insomnia: Addressing Shortcomings in OTC Medications

Use of Mind and Body Practices to Manage Insomnia

Introduction of a New Class of Agents: TYK2 Inhibitors

Emerging Topical Therapy Options for Plaque Psoriasis

Role of HCPs in the Management of Vitiligo

Real-World Impact of Vitiligo